The clinical response of psoriatic patients to treatment by 1α (OH)vitamin D3 may be predicted by the sensitivity of their peripheral blood mononuclear cells to cAMP elevating agents and to 1,25-dihydroxyvitamin D3

✍ Scribed by Koren, R.; Ravid, A.; Segal, R.; Maron, L.; Arie, R.; Shohat, B.; David, M.; Sandbank, M.; Liberman, U.A.

• Book ID: 123211151
• Publisher: Elsevier Science
• Year: 1992
• Tongue: English
• Weight: 204 KB
• Volume: 17
• Category: Article
• ISSN: 0169-6009
• DOI: 10.1016/0169-6009(92)91798-N